Real-world practice patterns and attitudes towards de-escalation of bone-modifying agents in patients with bone metastases from breast and prostate cancer: A physician survey

BACKGROUND: There remain questions around the optimal use of bone-modifying agents (BMAs) in patients with bone metastases from breast and castration-resistant prostate cancer (CRPC). A physician survey was performed to identify current practices, as well as perceptions around long-term BMA use, BMA...

Descripción completa

Detalles Bibliográficos
Autores principales: AlZahrani, Mashari, Clemons, Mark, Vandermeer, Lisa, Sienkiewicz, Marta, Awan, Arif Ali, Hutton, Brian, Pond, Gregory R., Ng, Terry L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689398/
https://www.ncbi.nlm.nih.gov/pubmed/33294318
http://dx.doi.org/10.1016/j.jbo.2020.100339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689398/
https://www.ncbi.nlm.nih.gov/pubmed/33294318
http://dx.doi.org/10.1016/j.jbo.2020.100339

Ejemplares similares